Total: 4 |
|
PMID (PMCID) | ||
---|---|---|
30788073 |
OTHER | |
Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report. | ||
Upreti S, Fayyaz B, Bongu RP. J Community Hosp Intern Med Perspect. 2019;9(1):33-35. |
||
However, an entity called Immune Mediated Necrotizing Myopathy (IMNM), a type of autoimmune mediated myopathy, has been recognized and characterized in patients with history of statin exposure where there is persistence of proximal muscle weakness, CK elevation and myofiber necrosis can be seen on muscle biopsy even after stopping statins. | ||
27922497 |
MIXED_SAMPLE | Middle Aged |
Autoimmune Myopathies. | ||
Mammen AL. Continuum (Minneap Minn). 2016;22(6, Muscle and Neuromuscular Junction Disorders):1852-1870. |
||
The most common subtypes of autoimmune myopathies are dermatomyositis, immune-mediated necrotizing myopathy, antisynthetase syndrome, and overlap syndromes; isolated polymyositis is an exceptionally rare disease. | ||
22436377 |
FEMALE | |
A pediatric patient with myopathy associated with antibodies to a signal recognition particle. | ||
Kawabata T, Komaki H, Saito T, Saito Y, Nakagawa E, Sugai K, Sasaki M, Hayashi YK, Nishino I, Momomura M, Kizawa T, Imagawa T, Yokota S. Brain Dev. 2012;34(10):877-80. |
||
We report the case of a 15-year-old Japanese girl with myopathy associated with antibodies to a signal recognition particle (anti-SRP myopathy). | ||
12235311 |
MIXED_SAMPLE | Adult |
Myopathy with antibodies to the signal recognition particle: clinical and pathological features. | ||
Miller T, Al-Lozi MT, Lopate G, Pestronk A. J Neurol Neurosurg Psychiatry. 2002;73(4):420-8. |
||
The anti-SRP myopathy was compared with myopathology in other types of inflammatory and immune myopathies. |